Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany. Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print]
Gründer G, Mertens L, Spangemacher M, Schmitz C. [Can antidepressants negatively alter the long-term course of depressive disorders?]. Nervenarzt. 2025 96(2):146-152. Epub 2025 Feb 24.
Schmitz CN, Hart XM, Spangemacher M, Roth JL, Lazarevic I, Oberthür G, Büsing KA, Becker R, Cumming P, Gründer G. Neurovascular coupling of striatal dopamine D receptor availability and perfusion using simultaneous PET/MR in humans. Neurosci Appl. 2025 3:104094.
Spangemacher M, Reinwald J, Adolphi H, Kärtner L, Mertens LJ, Schmitz CN, Gründer G. [Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment]. Nervenarzt. 2025 96(2):119-127. Epub 2025 Jan 16.
Spangemacher M, Schmitz C, Cumming P, Färber LV, Hart XM, Uchida H, Gründer G. The sense and nonsense of antipsychotic combinations: A model for dopamine D receptor occupancy. Transl Psychiatry. 2025 15(1):348.